Sandoz to Pay $265 Mln in U.S. to Solve Generic Drug Antitrust Litigation

By Mauro Orru Sandoz Group said its U.S. subsidiaries would pay $265 million to settle a generic pharmaceuticals pricing antitrust litigation. The maker of...

Related Keywords

Pennsylvania ,United States ,Mauro Orru ,Us District Court ,Sandoz Group ,Eastern District ,Article Normal ,Pharmaceuticals ,Healthcare Life Sciences ,Generic Biosimilar Drugs ,Anti Competition Issues ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Sdz Eb ,Ch Sdz ,Ch1243598427 ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,Generic ,Biosimilar Drugs ,